Recent Posts

RT @ThomasCiullaMD: Just published, “Suprachoroidal delivery enables targeting, …

[ad_1] RT @ThomasCiullaMD: Just published, “Suprachoroidal delivery enables targeting, localization and durability of small molecule suspensions”… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ModernRetina: WATCH: Acing the suprachoroidal injection for targeted drug de…

[ad_1] RT @ModernRetina: WATCH: Acing the suprachoroidal injection for targeted drug delivery #Ophthalmology #retina https://t.co/3zwxF2tMfP http… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

Our paper, “Longer-Term Anti-VEGF Therapy Outcomes in Neovascular #AMD, #DME, a…

[ad_1]

Our paper, https://t.co/vztXKnKI4P “Longer-Term Anti-VEGF Therapy Outcomes in Neovascular #AMD, #DME, and RVO-Related Macular Edema” now appears in print, in this month’s Ophthalmology Retina.
More effective & durable therapies are needed.
#eyes #retina #diabetes https://t.co/aOsmK3A9fx
[ad_2]

Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @ThomasCiullaMD: Recently published, “Suprachoroidal Drug Delivery for Clinic…

[ad_1] RT @ThomasCiullaMD: Recently published, “Suprachoroidal Drug Delivery for Clinicians: Anatomic Principles, Clinical Data in Uveitis, and Fu… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Just published: Progress in the pharmacotherapy of uveitis:…

[ad_1] RT @ThomasCiullaMD: Just published: Progress in the pharmacotherapy of uveitis: the art of personalized care https://t.co/4gQ6cbQogQ [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

RT @RetinaToday: You are invited to attend a CME Symposium in Chicago in-person …

[ad_1]
RT @RetinaToday: You are invited to attend a CME Symposium in Chicago in-person or virtual during the #AAO2022 Annual Meeting: Into the #S…
[ad_2]

Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @ModernRetina: The Phase 2 Altitude study evaluates the efficacy, safety, and…

[ad_1] RT @ModernRetina: The Phase 2 Altitude study evaluates the efficacy, safety, and tolerability of suprachoroidal delivery of RGX-314 in pati… [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

Just published, “Suprachoroidal delivery enables targeting, localization and dur…

[ad_1] Just published, “Suprachoroidal delivery enables targeting, localization and durability of small molecule suspensions” in the Journal of Controlled Release, a high-impact leading journal on #drugdelivery systems & formulations! #suprachoroidal #retina https://t.co/25dGszj795 [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.

Recently published, “Suprachoroidal Drug Delivery for Clinicians: Anatomic Princ…

[ad_1]
Recently published, “Suprachoroidal Drug Delivery for Clinicians: Anatomic Principles, Clinical Data in Uveitis, and Future Directions”
This paper reviews #suprachoroidal space anatomy, biomechanics, microinjector, #Xipere, #genetherapy & other trials.
https://t.co/OXcGgMU7Fv
[ad_2]

Source by Thomas Ciulla, MD, MBA

Return to main website.

Just published: Progress in the pharmacotherapy of uveitis: the art of personal…

[ad_1] Just published: Progress in the pharmacotherapy of uveitis: the art of personalized care https://t.co/4gQ6cbQogQ [ad_2] Source by Thomas Ciulla, MD, MBA Return to main website.